Market Exclusive: Weekly Biotech Report Part II, Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) May 24, 2016 In the News
Reuters: Oramed Says Oral Insulin Succeeds in Midstage Type 2 Diabetes Trial May 24, 2016 In the News
Be Forum: Dancing With Dragons, How a Small Israeli Company Struck a Historic Deal with a Chinese Giant February 15, 2016 In the News
Seeking Alpha: $50 Million Plus Royalties Deal Indicates Bright Future For Oramed’s Oral Insulin December 22, 2015 In the News
Stock News Now (video): Oramed Pharmaceuticals, Inc. – Developing Platform Technology for Oral Delivery of Drugs with Focus on Diabetes November 11, 2015 In the News
BioPharma Dive: A 21st century diabetes option: Will Oramed be first to market with oral insulin? July 12, 2015 In the News
